"Adaptive pathways" to drug authorisation: adapting to industry?

BMJ (Clinical research ed.)

Volumn 354, Issue , 2016, Pages i4437-

  Davis, Courtney ^a   Lexchin, Joel ^a   Jefferson, Tom ^a   Gøtzsche, Peter ^a   McKee, Martin ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; DRUG APPROVAL; DRUG CONTROL; DRUG INDUSTRY; DRUG THERAPY; EUROPE; HUMAN; PROCEDURES; RISK ASSESSMENT; TIME FACTOR;

DRUG AND NARCOTIC CONTROL; DRUG APPROVAL; DRUG INDUSTRY; DRUG THERAPY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EUROPE; HUMANS; RISK ASSESSMENT; TIME FACTORS;

EID: 84991747631     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i4437     Document Type: Article

References (0)